Position in RNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,419,234
New position
Shares Held
180,945
first reported quarter
Ownership
1.06%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Slotnik Capital, LLC holds $47,155,333 across 5 Biotechnology names. RNA ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TERN |
Terns Pharmaceuticals, Inc.
|
420,700 | $22,179,304 | |
| 2 | ACLX |
Arcellx, Inc.
|
118,000 | $13,548,760 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
135,000 | $5,431,050 | |
| 4 | DAWN |
Day One Biopharmaceuticals, Inc.
|
166,837 | $3,576,985 | |
| 5 | RNA |
Atrium Therapeutics, Inc.
This page
|
180,945 | $2,419,234 |
All Filings in RNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,419,234 | 180,945 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||